| Aug 21 2024 |
D.C. Circuit Court Upholds EPA’s Assessment of Cancer Risk from Ethylene Oxide |
CMBG3 Law |
| Aug 21 2024 |
Canada Begins 60-Day Comment Period on Computational Tool for Chemical Screening and Prioritization |
Bergeson & Campbell, P.C. |
| Aug 20 2024 |
Whistleblower Stops Medicaid Fraud at Crossroads |
Tycko & Zavareei LLP |
| Aug 20 2024 |
CMS 2026 IRA Price Negotiations Results Likely to Create Upstream and Downstream Effects |
Mintz |
| Aug 20 2024 |
CMS Releases Final Procedural Notice on Transitional Coverage for Emerging Technology (TCET) |
McDermott Will & Schulte LLP |
| Aug 19 2024 |
CMS Issues Final Notice on Program for Breakthrough Device Reimbursement but Industry Looks to Congress for More Inclusive Solution |
Mintz |
| Aug 19 2024 |
Artificial Intelligence: Is the Health Care Sector Ready for the Rollout? |
Foley & Lardner LLP |
| Aug 19 2024 |
Recent Health Plan Litigation Puts Family Building Benefits in Focus |
Proskauer Rose LLP |
| Aug 16 2024 |
Federal Trade Commission Hashes Out Aggressive Interpretation of Data Anonymization: What You Need to Know |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Aug 16 2024 |
CMS Rules Propose Changes Regarding the Medicare Prescription Drug Inflation Rebate Program, Refundable Drugs, Skin Supplements and More; Comments Due September 9 |
Epstein Becker & Green, P.C. |
| Aug 16 2024 |
M+ Check-Up (Special Regulatory Edition): August 16, 2024 |
McDermott Will & Schulte LLP |
| Aug 16 2024 |
Trending in Telehealth: July 30 – August 12, 2024 |
McDermott Will & Schulte LLP |
| Aug 16 2024 |
Dental Office and Its Founders and Owners Agree to Pay Over $6 Million to Resolve FCA Allegations |
ArentFox Schiff LLP |
| Aug 16 2024 |
What To Expect for the IPO Market in the Second Half of 2024 |
Foley & Lardner LLP |
| Aug 16 2024 |
CMS Issues Mandatory “TEAM Model” for Acute Care Hospitals to Improve Episode-Based Alternative Payments and Advance Accountable Care Relationships |
Epstein Becker & Green, P.C. |
| Aug 15 2024 |
United Arab Emirates | Health Insurance for Tourist Visas |
Berry Appleman & Leiden |
| Aug 15 2024 |
The Gloves Are Off: DOJ Whistleblower Pilot Program Set To Shore Up ‘Gaps’ In Private Payer Healthcare Enforcement |
Barnes & Thornburg LLP |
| Aug 15 2024 |
Recent Supreme Court Decisions and the DSCSA |
Epstein Becker & Green, P.C. |
| Aug 15 2024 |
Stark Integrity Podcast: Mission Improbable, Open Payments, DHS, CIAs & IROs, and Criminal National Health Care Fraud Enforcement Action Episodes [Podcast] |
Nelson Mullins |
| Aug 15 2024 |
Workplace Liability When a Third Party is Negligent |
Stark & Stark |
| Aug 15 2024 |
FTC Releases Controversial Interim Staff Report on PBMs’ Purported Impact on Drug Prices |
Epstein Becker & Green, P.C. |
| Aug 15 2024 |
FDA Rolls Out Innovative New Designation Programs in Response to Congressional Mandates |
Mintz |
| Aug 15 2024 |
No Surprises Here! Fifth Circuit Upholds Health Care Provider Challenge to No Surprises Act Regulations |
Proskauer Rose LLP |
| Aug 14 2024 |
DOJ Files False Claims Act Suit against Public Health System Alleging Widespread Stark Law Violations for Excessive Physician Compensation |
Mintz |
| Aug 14 2024 |
This Week in 340B: August 6 – 12, 2024 |
McDermott Will & Schulte LLP |
| Aug 14 2024 |
Medical Diagnostic Equipment Accessibility Regulations Announced by DOJ Under Title II of ADA |
Epstein Becker & Green, P.C. |
| Aug 14 2024 |
Krazati Untitled Letter: A Cautionary Tale for CFL Promotion of Accelerated Approval Drugs |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 14 2024 |
No Surprises Here! CMS Audit Uncovers Non-Compliance by Aetna in Calculation and Disclosure Requirements Under the No Surprises Act |
Proskauer Rose LLP |
| Aug 14 2024 |
Whistleblowers: The Fluoride to Dental Practices’ PPP Fraud Decay |
Tycko & Zavareei LLP |
| Aug 13 2024 |
A New Prescription for Access: The Department of Justice Celebrates Anniversary of the ADA by Finally Issuing Title II Medical Diagnostic Equipment Accessibility Regulations |
Epstein Becker & Green, P.C. |
| Aug 13 2024 |
Affordable Care Act Overpayments in the CY 2025 Medicare Physician Fee Schedule Proposed Rule: Implications for False Claims |
Epstein Becker & Green, P.C. |
| Aug 13 2024 |
DOJ and Whistleblowers Crack Down on Illegal Kickbacks: Major Qui Tam Settlements from July 2024 |
Kohn, Kohn & Colapinto |
| Aug 13 2024 |
Cancer Drugs: Antibody-Drug Conjugate Litigation |
Foley & Lardner LLP |
| Aug 13 2024 |
Violations for Excessive Physician Compensation |
Mintz |
| Aug 13 2024 |
IRS Audits & Ongoing Scrutiny of Nonprofit Hospitals – Key Background & Action Steps |
Sheppard, Mullin, Richter & Hampton LLP |
